As a result of their ability to integrate into the genome of both dividing and non-dividing cells, lentiviruses have emerged as a promising vector for gene delivery. Targeted gene transduction of specific cells and tissues by lentiviral vectors has been a major goal, which has proven difficult to achieve. We report a novel targeting protocol that relies on the chemoselective attachment of cancer specific ligands to unnatural glycans on lentiviral surfaces. This strategy exhibits minimal perturbation on virus physiology and demonstrates remarkable flexibility. It allows for targeting but can be more broadly useful with applications such as vector purification and immunomodulation.
Keywords: Bioorthogonal chemistry; Cancer; Gene therapy; Lentivirus; Metabolic labeling; Sialic acid; Surface engineering; Targeting; Tumor angiogenesis; Unnatural glycans.
Copyright © 2015 Elsevier Inc. All rights reserved.